Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07077070 · ClinicalTrials.gov registry record · NA
Investigating Electrical Categorical Loudness Scaling Using a Mobile Research App in Experienced Adult Cochlear Implant Participants
A NA study, sponsored by Cochlear.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT07077070 is a NA study that has completed, run by Cochlear. The registered enrollment target is 20 participants.
The verdict
NCT07077070, a NA study, has completed, sponsored by Cochlear.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This clinical study will evaluate a feature of the investigational Nexus Research System used for programming cochlear implants. Programming a cochlear implant-commonly referred to as MAP fitting-involves activating the device, allowing recipients to acclimatize to hearing sounds, and then fine-tuning the program based on the user's perception of loudness across different sounds. This process typically occurs over several visits and requires a clinician to collect data for the fine-tuning phase. The Nexus Research System includes an "Electrical Loudness Scaling" task, which participants can complete independently using a mobile application to collect the necessary data. Based on findings from previous studies, this feature has been revised to enable faster data collection. The current study will assess the performance of the updated feature. The study will involve experienced cochlear implant users. Participants will use the feature, undergo a series of hearing assessments-including evaluations of loudness perception-and provide feedback on the updated feature.
Interventions
- DEVICE Standard Electrical Categorical Loudness Scaling task (Standard-ELS)
- DEVICE Fast Electrical Categorical Loudness Scaling task (Fast-ELS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-10-21 |
| Est. Completion | 2025-12-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07077070
The ClinicalTrials.gov registry entry for NCT07077070 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cochlear, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard Electrical Categorical Loudness Scaling task (Standard-ELS) is the first listed.
NCT07077070 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07077070 about?
NCT07077070 is a clinical study titled "Investigating Electrical Categorical Loudness Scaling Using a Mobile Research App in Experienced Adult Cochlear Implant Participants". This clinical study will evaluate a feature of the investigational Nexus Research System used for programming cochlear implants. Programming a cochlear implant-commonly referred to as MAP fitting-involves activating the device, allowing recipients to acclimatize to hearing sounds, and then fine-tun...
What is the current status of trial NCT07077070?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2025-10-21. Estimated completion is 2025-12-24.
What interventions are being tested in trial NCT07077070?
The interventions under investigation include: Standard Electrical Categorical Loudness Scaling task (Standard-ELS) (DEVICE), Fast Electrical Categorical Loudness Scaling task (Fast-ELS) (DEVICE).
Who is sponsoring clinical trial NCT07077070?
This trial is sponsored by Cochlear, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.